Skip to main content
OpenTrials

Clinical trial condition

Stage IV Prostate Cancer

Explore clinical trials studying Stage IV Prostate Cancer. Study availability and eligibility vary by location and protocol.

78 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Stage IV Prostate Cancer trial results

Completed

CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT01881867

Conditions
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Genital Diseases, +11 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 16 locations
View Trial Details
Completed

Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer

NCT01543776

Conditions
Castration-resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • North Shore University Health System Evanston, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
View Trial Details
Completed

Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

NCT01026623

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
View Trial Details
Completed

Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

NCT01270880

Conditions
Adenocarcinoma of the Prostate, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • University of Medicine nd Denistry of New Jersey Piscataway, New Jersey, United States
  • University of Wisconsin Cancer Center Riverview Wisconsin Rapids, Wisconsin, United States
View Trial Details
Completed

Tivantinib in Treating Patients With Metastatic Prostate Cancer

NCT01519414

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +11 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Michael Reese Hospital Chicago, Illinois, United States
View all 20 locations
View Trial Details

Related conditions